Aug 10, 2023 / 09:00PM GMT
Operator
Good afternoon, ladies and gentlemen, and welcome to the Rain Oncology, Inc. Second Quarter 2023 Earnings Conference Call. (Operator Instructions) This call is being recorded on Thursday, August 10, 2023.
And I would now like to turn the conference call over to Mr. Dan Ferry of LifeSci Advisors. Please go ahead.
Daniel Ferry - LifeSci Advisors, LLC - MD & Relationship Manager
Thank you, operator, and good afternoon, everyone. With me today on the phone is Avanish Vellanki, Chief Executive Officer of Rain Oncology; and Nelson Cabatuan, acting as VP of Finance. Following the call, Dr. Robert Doebele, Chief Scientific Officer and Chief Medical Officer, will be joining Avanish and Nelson for a short Q&A.
Earlier today, Rain issued a news release announcing the company's results for the second quarter of 2023. Copies of this news release and SEC filings can be found in the Investors section of our website. Full details on updates from the quarter can be found in our news release and 10-Q issued today.
Before we begin, I would like
Q2 2023 Rain Oncology Inc Earnings Call Transcript
Aug 11, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers